Company / Operating Cash Flow
BIOTRICITY INC. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$2.4M
FY2025
5-year range
-$15.2M / -$2.4M
FY2021-FY2025
Trend
+64.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$14M to -$2M over the past 2 years.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from -$14M to -$2M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 64.4% year-over-year.
- Lowest operating cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -22.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.4M | +64.4% |
| FY2024 | -$6.7M | +50.6% |
| FY2023 | -$13.5M | +0.0% |
| FY2022 | -$13.5M | +10.7% |
| FY2021 | -$15.2M | -36.8% |
| FY2020 | -$11.1M | -40.9% |
| FY2019 | -$7.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026